COSTEM - 4th International Congress on Stem Cell Transplantation and Cellular Therapies

he 4th International Congress on Stem Cell Transplantation and Cellular Therapies (COSTEM) is taking place this year on October 26-29 in Berlin, Germany.

In its sessions, controversial topics will be addressed encouraging open discussions between international experts in a variety of fields:

Topics include among others:

  • Can CAR-T cell therapy replace allogeneic SCT in ALL?
  • Can allogeneic SCT in ALL be replaced by antibody therapy?
  • Can CAR-T cell therapy replace autologous SCT in relapsed diffuse large B-cell lymphoma?
  • Do we still need ex-vivo T-cell depletion for haploidentical SCT?
  • How to harness optimal GvL by T-cells?
  • Drug vs. cell therapy for viral Infection
  • For preventing relapse should DLI by donor T-cell be genetically manipulated?
  • How to harness optimal GvL by T-cells?

Early registration is open!

More information on the COSTEM website.